Tag Archives: business development

Results from the BIO Convention 2013 Meeting Analysis of Therapeutic In/Out Licensors

BIO’s results from the BIO 2013 Convention 1×1 meeting analysis conducted to identify trends and intentions of therapeutic in-licensors and out-licensors were released today. The analysis looked at the meeting activity of 180 in-licensors attending the Chicago conference in terms of what therapeutic areas and stages of development were in highest demand. Of the 804 drug R&D companies, companies in Phase I/Rare Disease came out ahead as a group, with an average of >17 meetings/company. This was followed by Phase Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

Venture Capital Trends

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s Director of Industry Research & Analysis – and the latest on venture capital trends is no exception. In the U.S., biotech VC funding is flat, and start-up money is drying up. According to the National Venture Capital Association (NCVA), U.S. VC funding for biotech fell to $4.1 billion in 2012 (figure 1). This 17% drop was greater than the 10% Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

Finding Biotech in the Silicon Prairie

BIO International Convention

The Silicon Prairie is about more than technology companies and Internet start-ups. In fact, the biotech industry in Illinois employs nearly 80,000 people, according to a recent analysis by Battelle, and their salaries are double the salary of the average private sector worker in the state. As biotech executives from across the globe descend upon McCormick Place this week for the annual BIO International Convention, they will have an opportunity to see that the Chicago Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO One-On-One Partnering Kicks Off!

Joe Colangelo

Partnering kicked off this today at the Business Forum at the 2013 BIO International Convention, and the numbers so far show that we have a strong week ahead of us. Over 130,000 partnering meeting requests have been requested Almost 22,000 meetings are already scheduled 4,900 of those meetings are exhibitor partnering meetings For a more in-depth look at the types of companies being represented at and stats on how many partnering meetings are taking place, check out this interview with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Opening Up Innovation

Cancer

Open Innovation has become a major theme in the life sciences over the last couple of years. Most of the attention has focused on initiatives where big pharma offers access to non-core assets to outside researchers in the hope that they will develop them successfully or form collaborations. In Sweden, AstraZeneca have followed this path, but interest in the concept has spread further down the discovery chain, generating creative initiatives from universities, tech transfer organizations, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , ,